Showing 41 - 60 results of 101 for search '"leukaemia"', query time: 0.04s Refine Results
  1. 41
  2. 42
  3. 43
  4. 44
  5. 45
  6. 46
  7. 47

    Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement by Stephan Zaenker, Stefan Schweyer, Justin Hasenkamp, Lorenz Truemper, Gerald Wulf

    Published 2011-01-01
    “…Granulocytic sarcoma (GS) represents a rare type of extramedullar manifestation from the acute myeloid leukaemia (AML). We report the case of a patient with recurrences of AML M4eo leukaemia in the uterus and the small intestine at 3 and 5 years, respectively, after matched related peripheral blood stem cell transplantation (PBSCT). …”
    Get full text
    Article
  8. 48
  9. 49

    A Case of Abdominal Sarcoidosis in a Patient with Acute Myeloid Leukemia by Vadsala Baskaran, Amanda Goodwin, Lavanya Athithan, Ciro Roberto Rinaldi, Alfredo Addeo

    Published 2013-01-01
    “…We herein present a patient with acute myeloid leukaemia patient who, after chemotherapy, developed ascites that turned out to be abdominal sarcoidosis.…”
    Get full text
    Article
  10. 50

    Pitfalls in Diagnosis: JMML versus KMT2A Rearranged Juvenile AML by Liesbeth Vanheeswijck, Sanjay Tewari, Robin Dowse, Nicola Potter, Jelena Jovanovic, Caroline L. Furness, Elsje Van Rijswijk

    Published 2024-01-01
    “…Lysine methyltransferase 2A (KMT2A) rearrangements are commonly found in juvenile acute myeloid leukaemia (AML). Although distinct diseases, there is a known clinical overlap between KMT2A-rearranged AML and juvenile myelomonocytic leukaemia (JMML). …”
    Get full text
    Article
  11. 51

    Analysis of Signals Leading to Differentiation of Immature HL-60 after Administration of IL-4 by Simon Vassiliadis

    Published 1994-01-01
    “…Treatment of acute myeloid leukaemia (AML) cells with differentiation agents leads not only to the acquisition of normal phenotypes but also contributes to the understanding of special immuno-haematology issues. …”
    Get full text
    Article
  12. 52

    Acute Coronary Syndrome as an Unusual Initial Presentation of T-Prolymphocytic Leukemia: A Case Report and Review of the Literature by Christian R. Klein, Felix Jansen, Peter Brossart, Marco Herling, Georg Feldmann

    Published 2024-01-01
    “…T-prolymphocytic leukaemia (T-PLL) is the most common mature T-cell leukaemia in Central Europe and is often manifested by rapidly increasing lymphocytosis, marked bone marrow infiltration and splenomegaly. …”
    Get full text
    Article
  13. 53
  14. 54

    The Multi‐Kinase Inhibitor GZD824 (Olverembatinib) Shows Pre‐Clinical Efficacy in Endometrial Cancer by Dongli Liu, Dylan Glubb, Tracy O'Mara, Caroline E. Ford

    Published 2025-01-01
    “…GZD824, also known as olverembatinib, is a multi‐kinase inhibitor previously investigated in clinical trials for chronic myeloid leukaemia and Ph+ acute lymphoblastic leukaemia as a BCR‐ABL inhibitor. …”
    Get full text
    Article
  15. 55

    Leukemia Inhibitory Factor: Roles in Embryo Implantation and in Nonhormonal Contraception by Naguib Salleh, Nelli Giribabu

    Published 2014-01-01
    “…Leukaemia inhibitory factor (LIF) plays an indispensible role in embryo implantation. …”
    Get full text
    Article
  16. 56
  17. 57

    Haemorrhagic Colitis Caused by Dasatinib by Nishant Patodi, Nidhi Sagar, Zbigniew Rudzki, Gerald Langman, Naveen Sharma

    Published 2012-01-01
    “…Here we present a case of a 59-year-old man with chronic myeloid leukaemia (CML) developing the rarest complication of haemorrhagic colitis with dasatinib therapy which resolved rapidly after treatment withdrawal.…”
    Get full text
    Article
  18. 58

    Mitoxantrone and acquired Long-QT Syndrome. Case presentation. by Brandy Viera Valdés, Lázaro Enrique De la Cruz Aviléz

    Published 2009-05-01
    “…We report a patient with diagnosis of leukaemia who was treated with mitoxantrone and presented syncope. …”
    Get full text
    Article
  19. 59

    Oral Squamous Cell Carcinoma Arising in a Patient after Hematopoietic Stem Cell Transplantation with Bisphosphonate-Related Osteonecrosis of the Jaws by Paolo G. Arduino, Crispian Scully, Luigi Chiusa, Roberto Broccoletti

    Published 2015-01-01
    “…A 55-year-old man with a history of acute myeloid leukaemia treated with hematopoietic stem cell transplantation and with a 5-year history of bisphosphonate-related osteonecrosis of the jaws, following 12 cycles of intravenous zoledronic acid therapy, presented in December 2009 with a history of increasingly severe unilateral lower jaw pain. …”
    Get full text
    Article
  20. 60